Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
Posted in | Nanomaterials | Nanobusiness

Alfa Aesar Publishes New Pharmaceutical Services Brochure "Discovery to Market"

Published on October 21, 2009 at 9:19 PM

Alfa Aesar, a Johnson Matthey Company, has published a new "Discovery to Market" Pharmaceutical Services brochure that outlines services from Lab to Bulk API production provided by Alfa Aesar and Johnson Matthey Pharmaceutical Services.

The eight-page brochure details the chemical products and services offered by Alfa Aesar and Johnson Matthey Pharmaceutical Services to cover the full scope of the drug development pipeline. The pharmaceutical portfolio includes a catalog of over 30,000 building blocks and screening compounds, cGMP compliant commercial manufacturing and a full suite of services in between. Alfa Aesar and Johnson Matthey Pharmaceutical Services offer full regulatory and cGMP compliance in all aspects, including chemical development, catalytic screening, lab scale production and more.

To request a free copy of the Discovery to Market Pharmaceutical Services brochure, contact Alfa Aesar at 1-800-343-0660 or email info@alfa.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit